Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has issued an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has announced an update regarding its final cash dividend for the year ending December 31, 2024. The dividend is set at RMB 0.6 per share, with shareholders’ approval scheduled for June 10, 2025. The announcement includes details about the Hong Kong share register, ex-dividend date, and withholding tax rates applicable to different types of shareholders. This update is significant for stakeholders as it outlines the financial returns and tax implications for investors, reflecting the company’s financial health and commitment to shareholder value.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. operates in the biotechnology industry, focusing on the development and production of biological materials. The company specializes in products such as ophthalmic materials, medical aesthetics, and wound care solutions, with a market focus on the healthcare sector.
Average Trading Volume: 585,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.06B
For detailed information about 6826 stock, go to TipRanks’ Stock Analysis page.